Development of a therapeutic antibody targeting CADM1 for the treatment of ATLL

Shingo Nakahata

Presentation information

Poster Session

Fri.Oct,11

Poster Session 1-11 Malignant Lymphoma: HTLV-1/EBV/Others

Fri. Oct 11, 2019 5:40 PM - 6:15 PM Poster (Tokyo International Forum, B2F Hall E)

Chair: Kisato Nosaka (Department of Hematology, Kumamoto University Hospital)

[PS1-11-4] Development of a therapeutic antibody targeting CADM1 for the treatment of ATLL

Shingo Nakahata¹, Chilmi Syahrul¹, Tomonaga Ichikawa¹, Tadashi Matsuura², Gene Kurosawa³, Kazuhiro Morishita¹ (1.Div. Tumor&Cellular Biochem., Dept. Med. Sci., Miyazaki Univ, Miyazaki, Japan, 2.Perseus Proteomics Inc., Tokyo, Japan, 3.Fujita Health University, Aichi, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.